Advanced Search
Contact | Corporate | Help

Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy

Sponsors:
  • University of Michigan
  • Aastrom Biosciences
Phases:
  • Phase I
  • Phase II
IndicationsAcronym:
  • Alveolar Bone Defects
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Biological: Tissue Repair Cell therapy
  • Device: Tissue Repair Cells (TRC)
Enrollment:
24

Additional information about NCT00755911.


SourceSolution © 2008-2012